[1]
Dr. Syeda Sarah Abbas, “Multiple Sclerosis (MS) – Demyelinating Disorder; It’s Overview, Indications, Etiology, Pathophysiology and Clinical Pharmacotherapy”, World J Pharm Sci, vol. 3, no. 10, pp. 2029–2034, Oct. 2015.